Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
30 Cards in this Set
- Front
- Back
MOA of sulfonamides
|
Folate is made up of Pteridine, para-aminobenzoic acid (PABA), and glutamic acid.
Sulfonamides are competitive antagonists of PABA --> prevent formation of folic acid |
|
Why are sulfonamides selective?
|
Folic acid is an essential vitamin. We dont make it as we do not have dihydropteroate synthetase.
Bacteria cannot uptake folic acid so they make it. So disrupting it --> decrease in DNA replication and protein synthesis |
|
Which bacteris are resistant to sulfonamides and trimethoprim? and why?
|
Enterococcus faecalis and Enterococcus faecium.
They can absorb folic acid from the enviroment. |
|
sulfonamides bacteriostatic or bacteriocidal?
|
bacteriostatic
|
|
sulfonamides inhibit which enzyme?
What is this enzymes function? |
dihydropteroate synthase
bacterial enzyme responsible for incorporation of PABA into dihydropteroic acid the immediate precursor of folic acid. |
|
Trimethoprim are...
|
Is a structural analog of the pteridine portion of dihydrofolate
|
|
Sulfonamides are...
|
structural analogues and competitive antagonists of para-aminobenzoic acid (PABA),
|
|
Trimethoprim in hibits which enzyme?
What is this enzymes function? |
dihydrofolate reductase (DHFR).
DHFR is the enzyme responsible for conversion of dihydrofolate to tetrahydrofolate (hence to purines then to DNA). |
|
What classification are Sulfonamides
|
Broard spectrum
|
|
Where are Sulfonamides absorbed after oral admin?
|
Mainly in the small intestine, some in the stomach.
Vagina, resp. tract, abradded skin - variable and unreliable |
|
Sulfonamides peak plasma levels?
|
2-6hrs
|
|
How are Sulfonamides distributed in the body?
|
Widely through all tissue
|
|
Can you administer Sulfonamides parentally?
|
No, due to soluble sulfonamide salts are highly alkaline and irritating to the tissues.
|
|
Give 5 resistance mechanisms for sulfonamides
|
-Mutation allows synthesis of large amounts of PABA.
Some bacteria produce an DHPS (Dihydropteroate synthetase) with a lower affinity for sulfonamides. -Mutant enzyme - binds sulfonamides less well. -Decreased uptake of sulfa drugs. -Resistance is persistent and irreversible. -Resistance is class specific i.e. does not impart cross resistance to other antimicrobials. |
|
Give an example of synergistic therapy of sulfonamides
|
Sulfa + DHFR inhibitor
Used today to treat P. carinii pneumonia in HIV |
|
Give exmaples of species sulfonamides are effective against
|
Strept. pneumoniae, Strept. pyogenes, some strains of Staph. aureus, Cl. welchii, H. influenzae, H. ducreyi, Y. pestis, Nocardia asteroides, Chlamydiae (e.g. C. trachomatis).
Plasmodium, Pneumocystis and Toxoplasma spp. Neisseria, Shigella and other enterobacteria give variable results. E. coli in acute UTI may be sensitive. |
|
Do sulfonamides have G-ve &/or G+ve effects?
|
Both
|
|
How are sulphonamides metabolished?
|
Varying proportions of sulfonamides are conjugated, usually with acetate, and in such a state are antibacterially inactive.
All sulfonamides that are absorbed are excreted, together with the conjugated forms. Some achieve high concentrations in the urine. |
|
What happens with acetylated sulfonamides?
|
They tend to crystallise (CRYSTALLURIA) in the kidney if the urine is acidic.
|
|
List some toxicity and side effects of sulfonamides
|
-5% of all patients have some degree of hypersensitivity: Drug fever, skin rashes, photosensitivity, allergic myocarditis, anaphylaxis
-Patients deficient in glucose-6-phosphate - hemolytic anemia -Headache, dizziness, gastric and intestinal upsets. -Haematuria and anuria -Stevens-Johnson syndrome -Blood dyscrasias such as Aplastic anemia, Agranulocytosis -Crystalluria if normal adequate fluid intake is not sufficient (2-3 liters per day),alkalinisation. |
|
Contraindications of sulfonamides
|
-Hypersensitivity
-In patients with impaired renal functions -In patients with impaired hepatic functions -Pregnancy -Lactation |
|
Drug interactions with sulfonamides
|
-Oral anticoagulants NB Warfarin
-Sulfonylurea -Hydantoin anticonvulsants (sulfonamides potentiate their effect) |
|
Trimethoprim MOA
|
A synthetic anti-folate acting as a dihydrofolate reductase (DHFR) inhibitor.
a structural analogue of the pteridine portion of DHF so competitively inhibits DHFR catalyzing the reduction of DHF to THF. |
|
Which m/o are sensitive to Trimethoprim alone?
|
Escherichia, Klebsiella and H. influenzae.
|
|
Uses of Trimethoprim
|
-The first and still its major use is in combination with sulfamethoxazole.
-The combination (Co-trimoxazole) has been demonstrated to act synergistically. The potentiation is between 2X and 64X. -The mixture has been shown in some cases to be bactericidal. -The single-entity product is promoted for UTI. -and for long-term prophylaxis against UTI. -It may also be useful against respiratory tract infections. -It has been suggested that the use of the single drug may lead to an increase in the number of organisms resistant to TMP. -Prostatitis (extended courses). -Treatment and prophylaxis for pneumocystosis (plus steroids to avoid inflammation). -Well tolerated. |
|
ADME of Trimethoprim
|
-It is well absorbed orally reaching 1-2 mcg/mL two hours after a 160 mg dose.
-It is widely distributed in the tissues, reaches the prostate, lung and the sputum in high concentrations. -Penetrates the csf to give 20-44% of blood levels. 63% of the dose appears in the urine with only a small proportion conjugated (8%). -It is also excreted in breast milk and crosses the placenta. |
|
What is Co-trimoxazole
|
Trimethoprim with Sulfamethoxazole
SMX/TMP, SXT, TMP-SMX, TMP-SMZ or TMP-sulfaSeptrin (GSK), Bactrim (Roche) The introduction of trimethoprim with combination of sulfamethoxazole is a clinically effective antimicrobial agent. The combination is SYNERGISTIC and the drug becomes Bactericidal. |
|
Adverse effects of Trimethoprim
|
-TMP/SMX can cause true and pseudo renal failure
-Crystalluria by SMX causes acute renal -By blocking creatine secretion TMP may cause an increase in serum creatine but with no true decline in glomerular filtration rate (pseudo). -TMP may cause hyperkalemia. -TMP/SMX fairly insoluble so for i.v. use large volumes of diluent needed. Be aware with volume overloaded patients i.e. heart failure. -Rash mostly due to SMX (in HIV patients more common) -Toxic epidermal necrosis and Stevens-Johnson syndrome reported. -Haematological -dose dependent bone marrow suppression. Especially at higher conc’s in Pneumocystic infections. |
|
Therapeutic use of Co-trimoxazole
|
-Urinary Tract Infections:
-Treatment of uncomplicated lower urinary tract infections -Bacterial Respiratory tract infections: -Gastrointestinal infections -Infections by Pneumocytis carinii (an opportunistic infection in patients with AIDS) -Prophylaxis in Neutropenic patients. -Dosage depends on individual infection. |
|
Adverse effects of Co-trimoxazole
|
-Permanent impairment of renal function (crystal urea, urinary obstruction)
-In recommended doses the combination does not induce folic acid deficiency in normal persons, but can precipitate megaloblastosis, leukopenia or thrombocytopenia -In routine 75% of adverse effects involve skin as described in sulfonamides. -GIT – mostly nausea and vomiting – diarrhea is rare. -Mild jaundice (transient) -headache, depression and hallucinations. -Various types of anemia. -AIDS patients more susceptible to adverse effects. |